Bio-Thera Solutions Ltd.

Organon believes there is “considerable growth potential” for the Tofidence (tocilizumab-bavi) biosimilar to Genentech’s Actemra, after acquiring rights in the US for the product from Biogen, in a dea

Dr Reddy’s has gained rights to a pair of proposed Stelara (ustekinumab) and Simponi (golimumab) biosimilars in multiple markets in south-east Asia, after striking an exclusive commercialization agree

Intas Pharmaceuticals’ Accord Biopharma unit has bolstered its US biosimilar pipeline after striking a deal to become the exclusive commercial partner for Bio-Thera Solutions’ BAT2506 proposed biosimi

As China’s immuno-oncology market adapts to the ever-growing ranks of homegrown PD-1/L1-targeting agents, SinoCellTech has received approval for what will be the 17th product in the sector - but the f